Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v, 5mL Eye Drops

Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v eye drops treat ocular inflammation when antibacterial cover is also needed, including appropriate postoperative care. They combine a fluoroquinolone antibiotic with a corticosteroid.
Place the drops into the lower-eyelid pocket and close the eye gently without rubbing. Space another eye medicine by at least five minutes. Follow the planned course and taper schedule rather than repeatedly restarting steroid drops when redness returns.
Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV. Dexamethasone suppresses inflammatory mediators, reducing swelling and redness at the treated surface.
Stinging, discomfort, temporary blur or an unpleasant taste may occur. Prolonged steroid exposure can increase eye pressure, delay healing or encourage a secondary infection.
Avoid use in herpes or fungal eye disease. A history of glaucoma, corneal thinning, steroid-related pressure rise or quinolone allergy is relevant. Contact lenses should be avoided during an active eye infection.
Pairs bacterial control with suppression of inflammatory swelling when both actions are needed for the diagnosed condition.
No. Dexamethasone adds anti-inflammatory action and changes the precautions, especially for eye pressure and infections worsened by steroids.
No. Dexamethasone can reduce redness even when the underlying cause is not bacterial, so improvement in appearance alone does not confirm the diagnosis.
No. Bromfenac is an NSAID, whereas dexamethasone is a corticosteroid; their actions, dosing plans and adverse effects differ.
Repeated steroid exposure can conceal persistent infection and cause pressure elevation without obvious early symptoms.
It can indicate corneal inflammation or another problem beyond uncomplicated conjunctivitis and needs an eye examination.
Fluoroquinolone: an antibiotic class that inhibits bacterial DNA enzymes. Topoisomerase: an enzyme involved in copying and organising DNA. Steroid response: an individual reaction such as a pressure rise during corticosteroid use.; AR: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v قطرات للعين; FR: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v collyre; PT: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v colírio; ES: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v gotas oftálmicas; RU: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v глазные капли; ID: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v tetes mata; VI: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v thuốc nhỏ mắt; MS: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v titis mata; TL: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v patak sa mata; ZH-SG: Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v 滴眼液
International B2B Enquiry
Send a structured B2B enquiry for Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v, 5mL Eye Drops under Eye Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v, 5mL Eye Drops